CA2255804C - Methode antitumorale par administration de derives de partricine - Google Patents

Methode antitumorale par administration de derives de partricine Download PDF

Info

Publication number
CA2255804C
CA2255804C CA002255804A CA2255804A CA2255804C CA 2255804 C CA2255804 C CA 2255804C CA 002255804 A CA002255804 A CA 002255804A CA 2255804 A CA2255804 A CA 2255804A CA 2255804 C CA2255804 C CA 2255804C
Authority
CA
Canada
Prior art keywords
use according
derivative
partricin
cells
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002255804A
Other languages
English (en)
Other versions
CA2255804A1 (fr
Inventor
Tiberio Bruzzese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pro Aparts Investimentos e Consultoria Ltda
Original Assignee
Pro Aparts Investimentos e Consultoria Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Aparts Investimentos e Consultoria Ltda filed Critical Pro Aparts Investimentos e Consultoria Ltda
Priority to CA002255804A priority Critical patent/CA2255804C/fr
Priority to US09/258,822 priority patent/US6121244A/en
Publication of CA2255804A1 publication Critical patent/CA2255804A1/fr
Application granted granted Critical
Publication of CA2255804C publication Critical patent/CA2255804C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
CA002255804A 1997-09-19 1998-12-07 Methode antitumorale par administration de derives de partricine Expired - Fee Related CA2255804C (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002255804A CA2255804C (fr) 1998-12-07 1998-12-07 Methode antitumorale par administration de derives de partricine
US09/258,822 US6121244A (en) 1997-09-19 1999-02-26 Antitumoral method by administration of partricin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002255804A CA2255804C (fr) 1998-12-07 1998-12-07 Methode antitumorale par administration de derives de partricine

Publications (2)

Publication Number Publication Date
CA2255804A1 CA2255804A1 (fr) 2000-06-07
CA2255804C true CA2255804C (fr) 2009-07-28

Family

ID=29425801

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002255804A Expired - Fee Related CA2255804C (fr) 1997-09-19 1998-12-07 Methode antitumorale par administration de derives de partricine

Country Status (1)

Country Link
CA (1) CA2255804C (fr)

Also Published As

Publication number Publication date
CA2255804A1 (fr) 2000-06-07

Similar Documents

Publication Publication Date Title
US6943190B2 (en) Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
Drew et al. Azithromycin—spectrum of activity, pharmacokinetics, and clinical applications
ES2258566T3 (es) Combinaciones de farmacos (por ejemplo, clorpromacina y pentamidina) para el tratamiento de trastornos neoplasicos.
JP2888453B2 (ja) ニューモシスティス−カリニ肺炎の治療用または予防用の製薬組成物
ES2608285T3 (es) Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
JP2011173928A (ja) 癌処置のためのエポチロンの使用
EP1077718B1 (fr) Amelioration de l'activite des agents antibacteriens d'oxazolidinone au moyen de derives d'arginine
AU2927999A (en) Use of epothilones for the treatment of cancer
JPH0349893B2 (fr)
KR100738940B1 (ko) 산화적-독성 물질, 특히 심장독성 물질에 대한 보호효과를가진 약물
SK138597A3 (en) A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals
Sanfilippo et al. Biological activity of a new class of rifamycins Spiro-piperidyl-rifamycins
JP2007535525A (ja) β−カルボリン誘導体を含有する医薬組成物および癌を処置するためのそれらの使用
US5852033A (en) Methods of treatment using lamellarin-class alkaloids
EP0429585A1 (fr) Compositions de cytochalasine et procedes therapeutiques
US5514664A (en) 1,4-dihydropyridines for application in combatting resistance to drugs
EP0792148B1 (fr) Preparations therapeutiques a base de quassino des presentant une activite antineoplasique, antivirale et herbistatique
US5776912A (en) Lipophilic oligosaccharide antibiotic compositions
JPS61502055A (ja) 低減された毒性の薬剤調製物
Davila et al. Pharmacokinetics of azithromycin after single oral dosing of experimental animals
US6121244A (en) Antitumoral method by administration of partricin derivatives
De Cesare et al. Preclinical efficacy of ST1976, a novel camptothecin analog of the 7-oxyiminomethyl series
US5914321A (en) Antitumoral method by administration of partricin derivatives
Kassab DEVELOPMENT OF NOVEL ANTIMICROBIAL TETRACYCLINE ANALOG B (IODOCYCLINE) BY CHEMO-INFORMATICS.
US20090176888A1 (en) Composition comprising phytosphingosine or derivative thereof

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20131209